Abstract
Thin melanomas can metastasize and be lethal. The purpose of this review was to identify negative risk factors in patients with melanomas less than 0.76 mm thick. Six hundred and eighty-one (681) such patients are reviewed in this study. Of those referred without metastatic disease (583 patients), metastases developed in 4.8% after a mean followup of 3.6 years. Of those referred with metastatic disease (98 patients), mortality was 35% after a mean followup of 5.9 years. Male patients (p less than 0.04) and patients with axial primaries (p less than 0.05) were at an increased risk of metastasis. Severe histologic regression was present in 40% of the primary lesions that metastasized and in only 17% of similar lesions that did not (p less than 0.001). Increased age was associated with increased local skin metastases, but not with increased nodal or distant metastases. A prognostic model was designed, using two clinical risk factors (axial primary site and male sex) and two histologic risk factors (Clark's Level IV and severe histologic regression). The prognostic model identified a low-risk population--women with extremity primaries--with an actuarial risk of metastasis at 10 years that was less than 3%. Patients with either (1) both clinical risk factors or (2) one clinical risk factor and one histologic risk factor were identified as high-risk patients. Their actuarial risk of metastasis was 11% at 5 years and 22% at 10 years (p = 0.0084). Identifying high-risk and low-risk patients with thin melanomas may improve guidelines for the application of adjuvant therapies to this population.
Full text
PDF











Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALLEN A. C., SPITZ S. Malignant melanoma; a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer. 1953 Jan;6(1):1–45. doi: 10.1002/1097-0142(195301)6:1<1::aid-cncr2820060102>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
- Breslow A. In search of thin lethal melanomas. Surg Gynecol Obstet. 1976 Nov;143(5):799–799. [PubMed] [Google Scholar]
- Breslow A., Macht S. D. Evaluation of prognosis in Stage I cutaneous melanoma. Plast Reconstr Surg. 1978 Mar;61(3):342–346. doi: 10.1097/00006534-197803000-00006. [DOI] [PubMed] [Google Scholar]
- Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970 Nov;172(5):902–908. doi: 10.1097/00000658-197011000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clark W. H., Jr, From L., Bernardino E. A., Mihm M. C. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969 Mar;29(3):705–727. [PubMed] [Google Scholar]
- Day C. L., Jr, Mihm M. C., Jr, Sober A. J., Harris M. N., Kopf A. W., Fitzpatrick T. B., Lew R. A., Harrist T. J., Golomb F. M., Postel A. Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg. 1982 Jan;195(1):30–34. doi: 10.1097/00000658-198201001-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gromet M. A., Epstein W. L., Blois M. S. The regressing thin malignant melanoma: a distinctive lesion with metastatic potential. Cancer. 1978 Nov;42(5):2282–2292. doi: 10.1002/1097-0142(197811)42:5<2282::aid-cncr2820420528>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
- Holmes E. C., Clark W., Morton D. L., Eilber F. R., Bochow A. J. Regional lymph node metastases and the level of invasion of primary melanoma. Cancer. 1976 Jan;37(1):199–201. doi: 10.1002/1097-0142(197601)37:1<199::aid-cncr2820370128>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
- Kelly J. W., Sagebiel R. W., Blois M. S. Regression in malignant melanoma. A histologic feature without independent prognostic significance. Cancer. 1985 Nov 1;56(9):2287–2291. doi: 10.1002/1097-0142(19851101)56:9<2287::aid-cncr2820560924>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- Kelly J. W., Sagebiel R. W., Clyman S., Blois M. S. Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator. Ann Surg. 1985 Jul;202(1):98–103. doi: 10.1097/00000658-198507000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kuehnl-Petzoldt C., Keil H., Schoepf E. Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (less than or equal to 1.5 mm) melanoma. Arch Dermatol Res. 1984;276(3):151–155. doi: 10.1007/BF00414011. [DOI] [PubMed] [Google Scholar]
- McLean D. I., Lew R. A., Sober A. J., Mihm M. C., Jr, Fitzpatrick T. B. On the prognostic importance of white depressed areas in the primary lesion of superficial spreading melanoma. Cancer. 1979 Jan;43(1):157–161. doi: 10.1002/1097-0142(197901)43:1<157::aid-cncr2820430123>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
- Milton G. W., Shaw H. M., Farago G. A., McCarthy W. H. Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I). Br J Surg. 1980 Aug;67(8):543–546. doi: 10.1002/bjs.1800670804. [DOI] [PubMed] [Google Scholar]
- Naruns P. L., Nizze J. A., Cochran A. J., Lee M. B., Morton D. L. Recurrence potential of thin primary melanomas. Cancer. 1986 Feb 1;57(3):545–548. doi: 10.1002/1097-0142(19860201)57:3<545::aid-cncr2820570323>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
- Paladugu R. R., Yonemoto R. H. Biologic behavior of thin malignant melanomas with regressive changes. Arch Surg. 1983 Jan;118(1):41–44. doi: 10.1001/archsurg.1983.01390010031008. [DOI] [PubMed] [Google Scholar]
- Reintgen D. S., Vollmer R., Tso C. Y., Seigler H. F. Prognosis for recurrent stage I malignant melanoma. Arch Surg. 1987 Nov;122(11):1338–1342. doi: 10.1001/archsurg.1987.01400230126022. [DOI] [PubMed] [Google Scholar]
- Seigler H. F., Cox E., Mutzner F., Shepherd L., Nicholson E., Shingleton W. W. Specific active immunotherapy for melanoma. Ann Surg. 1979 Sep;190(3):366–372. doi: 10.1097/00000658-197909000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shaw H. M., McCarthy W. H., McCarthy S. W., Milton G. W. Thin malignant melanomas and recurrence potential. Arch Surg. 1987 Oct;122(10):1147–1150. doi: 10.1001/archsurg.1987.01400220057011. [DOI] [PubMed] [Google Scholar]
- Søndergaard K., Hou-Jensen K. Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases. Virchows Arch A Pathol Anat Histopathol. 1985;408(2-3):241–247. doi: 10.1007/BF00707986. [DOI] [PubMed] [Google Scholar]
- Søndergaard K. The intra-lesional variation of type, level of invasion, and tumour thickness of primary cutaneous malignant melanoma. Acta Pathol Microbiol Scand A. 1980 Sep;88(5):269–274. doi: 10.1111/j.1699-0463.1980.tb02496.x. [DOI] [PubMed] [Google Scholar]
- Woods J. E., Soule E. H., Creagan E. T. Metastasis and death in patients with thin melanomas (less than 0.76 mm). Ann Surg. 1983 Jul;198(1):63–64. doi: 10.1097/00000658-198307000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]